Summary
40 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 269% this fiscal year.
What to watch
- Revenue fell by 45% a year over the last 3 years.
- Out of every 100 MXN of revenue, only 0.5 MXN is left as net profit.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 51.0 MXN for 1 MXN of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (MXN)
Diluted EPS (MXN)
- Analyst estimate
Revenue fell by 21% a year over 5 years. Over the last 3 years it fell by 45% a year. For the next fiscal year analysts expect revenue to grow by 269%.
Growth in detailDoes it make money?
ReasonablyWhere 100 MXN of revenue goes
- Cost of sales 89 MXN
- Sales and administration 4.1 MXN
- Taxes and other 6.1 MXN
- Net profit 0.5 MXN
Net profit, industry median (Chemicals - Specialty) 5.9 MXN
Out of every 100 MXN of revenue, 0.5 MXN is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.